These new medications, like copyright and Semaglutide, represent a groundbreaking class of drugs called GLP-1 receptor activators. These drugs work by increasing the body's natural ability to secrete GLP-1, a chemical that helps manage glucose levels and food intake. First and foremost, developed for managing type 2 diabetes, these medications have